Success Stories

The New England Journal of Medicine

The New England Journal of Medicine

Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New England Journal of Medicine logo, an article about Dr. Friedman’s brain cancer research and an acknowledgement to Rally for our support. “As a young investigator in 2013, I received my first grant directly supporting my lab research from Rally. The support enabled us to obtain the critical preclinical data needed for FDA approval to conduct the first pediatric trial of the therapy in recurrent high-grade gliomas,” shared Dr. Friedman. This week Dr. Friedman’s research was published in the New England Journal of Medicine, one of the most prestigious—if not the most prestigious—medical journals in the world. I often say at Rally we like to fund early, aren’t afraid of outside the box ideas and as long as the research is making progress, we will stick with...

read more
How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are specifically targeted towards these resistant tumor cells. Read part one here.   Dr. Kinnaman Seeks to Understand the Complexities of Osteosarcoma One of the first patients I saw as a fellow at MSK Kids, Memorial Sloan Kettering’s Pediatric program, was a 12-year-old boy with newly diagnosed osteosarcoma of his right thigh bone. Osteosarcoma is the most common malignant bone tumor in children and...

read more
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational Research at SCH. He transitioned into his role as chair this month, taking the reins from fellow Rally-funded Researcher, Medical Advisory Board member and current COG chair, Dr. Peter Adamson. At Rally, we work endlessly to uphold our mission of funding childhood cancer research in hopes of finding better treatments with fewer long-term side effects and ultimately, a cure. We believe that every child...

read more
2019 Rally Foundation Year In Review

2019 Rally Foundation Year In Review

Thank you for caring about kids fighting cancer, and thank you for giving toRally For Their Future. Rally Kid Brecklynn, who is six years old and has fought cancer twice, put it best: She said that all she wanted was to be a “plain girl,” meaning she just wanted to be a normal little girl playing dress up and having tea parties—not getting needle pokes and chemo cocktails. Your financial gift allows kids like Brecklynn, who are fighting cancer, to have the chance to be a “plain kid.” Your gift truly gives hope For Their Future. Cancer takes so much from these precious kids. The drugs used to treat them are harsh, outdated and come with a plethora of harmful side effects. Rally Kid Keren endured painful treatments. Not only did she lose her hair and a year of school, but she also lost her leg. Kids with cancer need you. We need you. We cannot do this without you. We are philanthropic...

read more
How Rally Kid Ruby is Making an Impact on Childhood Cancer Research

How Rally Kid Ruby is Making an Impact on Childhood Cancer Research

You might remember Rally Kid Ruby from Year End Giving three years ago. She was diagnosed with embryonal rhabdomyosarcoma, a form of soft tissue cancer, on April 17, 2015. As part of her cancer treatment, she underwent a brutal combination of chemotherapy and proton radiation. Despite the ups and downs of her battle with cancer, Ruby is now thriving. As a 15-year-old sophomore, she is working to make an impact on childhood cancer research. Watch the videos below to see the difference she is making and how your donations can help make an impact #fortheirfuture. In this video, Ruby shares her story, revealing the side effects of treatment that she’s still fighting today and what motivated her to give back.Ruby’s Dad, Dr. Jonathan Kaufman, is an adult oncologist. In this video, he recounts the heartbreaking moment when he found out that his daughter had cancer.Ruby’s Dance ‘Til You Drop...

read more
Research for Recurrent Brain Tumors Shows Promising Preliminary Results

Research for Recurrent Brain Tumors Shows Promising Preliminary Results

As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the common cold sore virus, otherwise known as herpes simplex or G207. Thanks to Rally Foundation funding, Dr. Friedman and his team were able to alter the virus to kill cancer cells, while also obtaining critical preclinical data needed to conduct a pediatric study. So far, out of seven children, the early results show the therapy to be safe, tolerable and promising. In order to gain a better understanding of his research and the clinical trials, we sat down with Dr. Friedman to find out the following: how pediatric...

read more

$

Sign up for our emails!

Fill out my online form.

Recent Posts

Success Stories

The New England Journal of Medicine

The New England Journal of Medicine

Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New England Journal of Medicine logo, an article about Dr. Friedman’s brain cancer research and an acknowledgement to Rally for our support. “As a young investigator in 2013, I received my first grant directly supporting my lab research from Rally. The support enabled us to obtain the critical preclinical data needed for FDA approval to conduct the first pediatric...

read more
How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are...

read more
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational...

read more
2019 Rally Foundation Year In Review

2019 Rally Foundation Year In Review

Thank you for caring about kids fighting cancer, and thank you for giving toRally For Their Future. Rally Kid Brecklynn, who is six years old and has fought cancer twice, put it best: She said that all she wanted was to be a “plain girl,” meaning she just wanted to be a normal little girl playing dress up and having tea parties—not getting needle pokes and chemo cocktails. Your financial gift allows kids like Brecklynn, who are fighting cancer, to have the chance to be a “plain kid.” Your gift...

read more
How Rally Kid Ruby is Making an Impact on Childhood Cancer Research

How Rally Kid Ruby is Making an Impact on Childhood Cancer Research

You might remember Rally Kid Ruby from Year End Giving three years ago. She was diagnosed with embryonal rhabdomyosarcoma, a form of soft tissue cancer, on April 17, 2015. As part of her cancer treatment, she underwent a brutal combination of chemotherapy and proton radiation. Despite the ups and downs of her battle with cancer, Ruby is now thriving. As a 15-year-old sophomore, she is working to make an impact on childhood cancer research. Watch the videos below to see the difference she is...

read more
Research for Recurrent Brain Tumors Shows Promising Preliminary Results

Research for Recurrent Brain Tumors Shows Promising Preliminary Results

As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the common cold sore virus, otherwise known as herpes simplex or G207. Thanks to Rally Foundation funding, Dr. Friedman and his...

read more

$

Sign up for our emails!

Fill out my online form.

Recent Posts

Volunteers are the heart of Rally's mission!

 

Enter your email below to receive details about our volunteer opportunities.

Thank you for your interest in volunteering with Rally! You should receive an email shortly with additional details.